Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 11:46 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 22,038,097 13.790% | 6,004,552 (+37.45%) | View |
| 2024-10-23 5:04 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | 22,918,324 14.300% | 22,918,324 (New Position) | View | |
| 2024-10-16 10:04 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | STATE STREET CORP STT | 9,919,865 6.200% | -1,612,223 (-13.98%) | View |
| 2024-02-09 3:12 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | LSV ASSET MANAGEMENT | 6,793,701 4.350% | -1,132,696 (-14.29%) | View |
| 2024-01-25 09:21 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | STATE STREET CORP STT | 11,532,088 7.390% | 352,510 (+3.15%) | View |
| 2024-01-22 2:03 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 25,978,899 16.600% | 207,707 (+0.81%) | View |
| 2024-01-10 10:16 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 16,033,545 10.270% | 1,300,976 (+8.83%) | View |
| 2023-07-07 4:21 pm Purchase | 13D | VectivBio Holding AG VECT | IRONWOOD PHARMACEUTICALS INC IRWD | 61,295,063 97.600% | 61,295,063 (New Position) | View |
| 2023-07-05 12:01 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -8,145,674 (Position Closed) | View |
| 2023-05-10 08:54 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -13,340,377 (Position Closed) | View |
| 2023-02-14 09:00 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BROWN CAPITAL MANAGEMENT LLC | 3,997,045 2.610% | -12,260,854 (-75.41%) | View |
| 2023-02-10 4:16 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | LSV ASSET MANAGEMENT | 7,926,397 5.170% | 7,926,397 (New Position) | View |
| 2023-02-09 11:22 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 14,732,569 9.600% | 1,244,807 (+9.23%) | View |
| 2023-02-06 2:53 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WELLINGTON MANAGEMENT GROUP LLP | 13,340,377 8.700% | -3,999,210 (-23.06%) | View |
| 2023-02-02 12:34 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | STATE STREET CORP STT | 11,179,578 7.290% | 11,179,578 (New Position) | View |
| 2023-01-26 08:52 am Unchanged | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 25,771,192 16.800% | 0 (Unchanged) | View |
| 2023-01-20 5:17 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 25,771,192 16.800% | -1,123,895 (-4.18%) | View |
| 2022-07-08 4:57 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 26,895,087 17.500% | 12,526,197 (+87.18%) | View |
| 2022-02-14 5:02 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BROWN CAPITAL MANAGEMENT LLC | 16,257,899 9.930% | -3,892,564 (-19.32%) | View |
| 2022-02-10 08:22 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 13,487,762 8.240% | -2,404,585 (-15.13%) | View |